Loading...
menu
Search
AI Chat
AI Strategies
Products
Markets
News
Resources
Pricing
Home
ETF
VYNE
VYNE
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
VYNE News
Amicus Therapeutics to Sell to BioMarin for $14.50 per Share
Dec 20 2025
Globenewswire
Ademi Firm Investigates VYNE for Potential Fiduciary Breaches in Yarrow Transaction
Dec 19 2025
PRnewswire
Monteverde & Associates Investigates VYNE Therapeutics Merger with Yarrow Bioscience
Dec 17 2025
PRnewswire
Crude Oil Increases by More Than 1%; General Mills Reports Earnings Exceeding Expectations
Dec 17 2025
Benzinga
Dow Rises by 150 Points as Jabil Reports Positive Earnings
Dec 17 2025
Benzinga
Yarrow and VYNE Merge, Anticipating $200 Million Financing
Dec 17 2025
Newsfilter
VYNE Therapeutics to Combine with Yarrow Bioscience, Obtains $200M Funding; Stock Prices Rise
Dec 17 2025
SeekingAlpha
Metagenomi (MGX) Reports Q2 Loss, Tops Revenue Estimates
Aug 12 2025
NASDAQ.COM
Downgrade Watchlist! These Are the Stocks Analysts Downgraded on 7/30/25
Jul 31 2025
TipRanks
Gold Gains 1%; Wingstop Shares Spike Higher
Jul 30 2025
Benzinga
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
Jul 30 2025
TipRanks
US Stocks Edge Higher; Kraft Heinz Earnings Top Views
Jul 30 2025
Benzinga
Why Is VYNE Therapeutics Stock (VYNE) Down 70% Today?
Jul 30 2025
TipRanks
VYNE Therapeutics Inc. (VYNE) Gets Buy Reaffirmation on Pipeline Progress
Jul 11 2025
Yahoo Finance
VOR Skyrockets On Ex-China Rights To Autoimmune Drug, ADIL To Face FDA On Jul.29, PSTV Jumps 14%
Jun 26 2025
NASDAQ.COM
FDA Puts VYNE Therapeutics Early-Stage Psoriasis Study On Hold
Apr 25 2025
Benzinga
Show More News
